Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,197
Closed -$478K 2263
2024
Q3
$478K Sell
10,197
-1,004
-9% -$45.8K 0.01% 1280
2024
Q2
$473K Sell
11,201
-6,326
-36% -$277K 0.01% 1185
2024
Q1
$775K Buy
+17,527
New +$799K 0.02% 781
2023
Q2
Sell
-8,361
Closed -$407K 1929
2023
Q1
$407K Buy
+8,361
New +$425K 0.01% 927
2022
Q2
Sell
-7,411
Closed -$385K 1938
2022
Q1
$385K Buy
+7,411
New +$382K 0.01% 1085
2020
Q4
Sell
-29,423
Closed -$1.63M 1069
2020
Q3
$1.63M Buy
29,423
+21,083
+253% +$1.09M 0.11% 138
2020
Q2
$379K Buy
+8,340
New +$373K 0.02% 354
2020
Q1
Sell
-9,431
Closed -$338K 866
2019
Q4
$338K Buy
+9,431
New +$351K 0.02% 535

Other funds holding QGEN

Centiva Capital's QGEN Position: Q4 2024 in Review

Centiva Capital sold out of Qiagen (QGEN) in Q4 2024, closing a stake of 10,197 shares — an estimated $478K sold.

Centiva Capital first reported a position in QGEN in Q4 2019 and held it in 8 quarters. The position peaked at $1.63M in Q3 2020. 325 funds tracked by Wall St. Rank hold QGEN as of Q4 2024.

  • Centiva Capital reported no remaining Qiagen position as of Q4 2024 after selling out during the quarter.
  • Centiva Capital sold 10,197 Qiagen shares in Q4 2024, an estimated $478K.
  • Centiva Capital first reported a position in Qiagen in Q4 2019 and held it in 8 quarters.
  • Centiva Capital's Qiagen position peaked at $1.63M in Q3 2020.
  • 325 funds tracked by Wall St. Rank held Qiagen as of Q4 2024.

Based on Centiva Capital's 13F filing for Q4 2024, filed 14 Feb 2025.